DAA1222 |
RELN promoter methylation increase |
Molecular |
brain, cerebral cortex |
Human |
RELN |
— |
|
DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|
DAA724 |
Global neuron loss |
Physiological |
cerebral cortex |
Human |
— |
— |
|
DAA732 |
Glial cell number |
Physiological |
cerebral cortex |
Human |
— |
— |
|
DAA1110 |
Dickkopf-like 1 |
Molecular |
frontal lobe |
Human |
DKKL1 |
Increase DNA Methylation |
|
DAA1072 |
CYFIP2 A to I mRNA editing decreases |
Molecular |
frontal lobe |
Human |
CYFIP2 |
Increase mRNA Editing |
|
DAA1082 |
Dipeptidyl-peptidase 8 |
Molecular |
frontal lobe |
Human |
DPP8 |
Increase DNA Methylation |
|
DAA2196 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
frontal lobe |
Human |
C1QC |
126.1% Increase Gene Expression Level |
|
DAA2153 |
complement component 4A increases with age |
Molecular |
frontal lobe |
Human |
C4A |
187.3% Increase Gene Expression Level |
|
DAA2198 |
complement component 3a receptor 1 increases with age |
Molecular |
frontal lobe |
Human |
C3AR1 |
89.0% Increase Gene Expression Level |
|
DAA2200 |
complement factor H increases with age |
Molecular |
frontal lobe |
Human |
CFH |
210.8% Increase Gene Expression Level |
|
DAA2199 |
complement component 5 increases with age |
Molecular |
frontal lobe |
Human |
C5 |
43.7% Increase Gene Expression Level |
|
DAA2159 |
complement factor H-related 1 increases with age |
Molecular |
frontal lobe |
Human |
CFHR1 |
144.2% Increase Gene Expression Level |
|
DAA2308 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
58.0% Decrease Gene Expression Level |
|
DAA2236 |
CD14 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD14 |
134.9% Increase Gene Expression Level |
|
DAA2201 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
25.5% Increase Gene Expression Level |
|
DAA2309 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
frontal lobe |
Human |
CXCL16 |
44.1% Increase Gene Expression Level |
|
DAA2203 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
56.5% Increase Gene Expression Level |
|
DAA1090 |
ATP/GTP Binding Protein-like 5 |
Molecular |
frontal lobe |
Human |
AGBL5 |
Increase DNA Methylation |
|
DAA2195 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
frontal lobe |
Human |
C1QB |
166.8% Increase Gene Expression Level |
|
DAA2197 |
complement component 1, s subcomponent increases with age |
Molecular |
frontal lobe |
Human |
C1S |
71.9% Increase Gene Expression Level |
|
DAA2287 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
283.0% Increase Gene Expression Level |
|
DAA2288 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
383.1% Increase Gene Expression Level |
|
DAA2307 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
61.1% Decrease Gene Expression Level |
|
DAA2248 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
frontal lobe |
Human |
CASP1 |
30.2% Increase Gene Expression Level |
|